适用于痛风的丁氧化酶抑制剂:应用和新药开发
Weiping Lyu1, Haoming Qin1, Xiaonan Zhou1
1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, PR China.
European journal of medicinal chemistry
|February 14, 2026
概括
本综述对治疗痛风的新型丁氧化酶 (XO) 抑制剂进行了分类,重点是克服当前药物 (如阿洛普林醇) 的局限性. 它探讨了包括双抑制剂和人工智能在内的先进策略,以开发更安全,更有效的痛风治疗方法.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 超尿血症直接引发了痛风性关节炎.
- 丁氧化酶 (XO) 是尿酸生产中的关键酶,也是痛风的治疗点.
- 目前的XO抑制剂 (allopurinol,febuxostat) 有过敏和心血管风险等局限性.
研究的目的:
- 系统地评估近期XO抑制剂研究的进展.
- 根据药物设计的演变,为XO抑制剂提出统一的分类框架.
- 确定开发更安全,更有效的抗痛风治疗方法的策略.
主要方法:
- 对针对XO的各种化学实体进行全面审查.
- 对各种抑制剂类的结构-活性关系 (SAR) 的分析.
- 探索尖端策略,如双重目标抑制和药物重用.
主要成果:
- 为XO抑制剂提出了一个新的分类框架.
- 结构-活性关系揭示了关键的药理和优化原则.
- 双重向抑制剂 (例如,XO/URAT1,XO/NLRP3) 和药物重定位显示出有希望的结果.
结论:
- 持续需要比目前的选择更安全,更有效的XO抑制剂.
- 像双目标抑制和人工智能驱动的优化等先进策略对于下一代痛风疗法至关重要.
- 这一审查为设计高效,低毒性抗痛风药物提供了蓝图.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.6K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.3K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
987
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
987


